drugset / Trial / NCT02973620
Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure
Summary
Open label study of levosimendan; planned comparison for effectiveness and safety to historic matched case controls from participating sites.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levosimendan | Other / unclassified | 0.2 ug/kg | Other |